Literature DB >> 30128633

Sublingual Immunotherapy in Allergic Rhinitis: Search for a Suitable Biomarker Continues!

Kana Ram Jat1, Arvind Kumar2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30128633     DOI： 10.1007/s12098-018-2773-2

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  9 in total

1.  Sublingual Immunotherapy Decreases Expression of Interleukin-33 in Children with Allergic Rhinitis.

Authors:  Yuanming Wang; Chuling Li; Yaxiong Xu; Deyu Xu; Gang Yang; Fang Liao; Xianglin Luo
Journal:  Indian J Pediatr       Date:  2018-05-23       Impact factor: 1.967

2.  Identification of specifically reduced Th2 cell subsets in allergic rhinitis patients after sublingual immunotherapy.

Authors:  F Ihara; D Sakurai; S Yonekura; T Iinuma; R Yagi; T Sakurai; T Ito; A Matsuura; Y Morimoto; T Arai; S Suzuki; K Katayama; T Nakayama; Y Okamoto
Journal:  Allergy       Date:  2018-09       Impact factor: 13.146

3.  Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.

Authors:  Zhong-Xi Wang; Han Shi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

4.  Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis.

Authors:  Minoru Gotoh; Osamu Kaminuma; Akihiro Nakaya; Kazufumi Katayama; Yuji Motoi; Nobumasa Watanabe; Mayumi Saeki; Tomoe Nishimura; Noriko Kitamura; Kazuko Yamaoka; Kimihiro Okubo; Takachika Hiroi
Journal:  Int Immunol       Date:  2017-06-01       Impact factor: 4.823

Review 5.  The role of interleukin-33 in rhinitis.

Authors:  Barbara Rogala; Joanna Glück
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

6.  Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity.

Authors:  Joanna Glück; Barbara Rymarczyk; Barbara Rogala
Journal:  Inflamm Res       Date:  2012-02-15       Impact factor: 4.575

Review 7.  Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report.

Authors:  Giovanni Battista Pajno; Roberto Bernardini; Diego Peroni; Stefania Arasi; Alberto Martelli; Massimo Landi; Giovanni Passalacqua; Antonella Muraro; Stefania La Grutta; Alessandro Fiocchi; Luciana Indinnimeo; Carlo Caffarelli; Elisabetta Calamelli; Pasquale Comberiati; Marzia Duse
Journal:  Ital J Pediatr       Date:  2017-01-23       Impact factor: 2.638

8.  Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis.

Authors:  S Zielen; P Devillier; J Heinrich; H Richter; U Wahn
Journal:  Allergy       Date:  2017-08-10       Impact factor: 13.146

9.  The Role of the Level of Interleukin-33 in the Therapeutic Outcomes of Immunotherapy in Patients with Allergic Rhinitis.

Authors:  Wail Fayez Nasr; Samir Sorour Sorour; Atef Taha El Bahrawy; Ghada Samir Boghdadi; Alia A El Shahaway
Journal:  Int Arch Otorhinolaryngol       Date:  2017-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.